Park Ji-won: "Party leadership race is heating up... We must seek a peaceful national convention"
"Honestly, I'm really worried," posted on Facebook
"Defeat in General Election: 'Bloodbath' If Administration Fails to Secure Re-election"
"A Cutthroat Party Convention, a Struggle for the Presidency, and the Disappearance of the Three Major Reforms"
[Edaily Reporter Ha Ji-na] On the 8th, Democratic Party lawmaker Park Jie-won stated, “The race for party leadership is becoming overly heated,” adding, “Frankly, I am overcome with deep concern.”
After posting this on Facebook on the 8th, Rep. Park added, “If we lose the general election and fail to retain power, there will be a bloodbath and we’ll all be finished,” urging that “we must seek a way to hold a peaceful party convention.”
Rep. Park wrote, “The second and third years of President Lee Jae-myung’s administration are a golden opportunity with no elections,” adding, “This is the golden time for the President to work. I anticipate that the ‘Yoon Again’ faction, including Jang Dong-hyuk, will collapse, and figures like Oh Se-hoon, Han Dong-hoon, Yoo Seong-min, and Lee Jun-seok may unite.”
Rep. Park pointed out, “A bloody party convention within our ruling party will inevitably lead to a power struggle for the presidency, and issues such as the people’s livelihood, the economy, and the resolution of internal strife—the three major reforms—will be sidelined.”Park Ji-won, Member of the National Assembly for the Democratic Party of Korea (Photo = Newsis)
The biggest bottleneck for AI servers is memory. As the KV cache—where large language models (LLMs) store past computations—accumulates, the required memory capacity increases exponentially. This prob…
Concerns about “tax risks” have been raised in some quarters of the financial investment, pharmaceutical, and biotech markets regarding Genosco, a subsidiary of OSCOTEC Inc.(039200)specializing in new…
As July began (June 29–July 3), the pharmaceutical and biotech industries turned their attention to Celltrion Pharm Inc.’s large-scale investment in production facilities and AriBio’s successful fundr…